 |
Deposito minimo $50 Promozione esclusiva |
Il nostro punteggio |
0% commissione |
Are you looking to buy Lineage Cell Therapeutics stocks? Chech our Reportlab with an in-depth review, check prices, statistics and see if buying this stock is interesting right now. This article will help you buy AMEX:LCTX! and analyze the company to see if this stock might be an interesting option to invest in. We will enlighten you about Lineage Cell Therapeutics stocks and how to buy and use them. Click on the button to start reading the review right now or scroll down for real time statistics about this company.
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing therapies for the treatment of degenerative diseases in the United States and internationally. The company’s lead product candidates include OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-related macular degeneration; OPC1, an oligodendrocyte progenitor cell therapy that is in Phase I/IIa multicenter clinical trial for the treatment of acute spinal cord injuries; and VAC2, an allogeneic cancer immunotherapy of antigen-presenting dendritic cells, which is in Phase I clinical trial to treat non-small cell lung cancer. It also develops Renevia, a facial aesthetics product that is in clinical trial for the treatment of HIV-associated facial lipoatrophy; HyStem, a biomaterial used for cell replacement and retention; and Premvia, a Hystem Hydrogel product, as well as develops bone grafting products for the orthopedic diseases and injuries. In addition, the company offers various therapeutic products for the treatment of oncology, neurological diseases and disorders, blood and vascular system diseases and disorders, and blood plasma volume expansion, as well as undertakes various research programs for vision restoration and Demyelination. Lineage Cell Therapeutics, Inc. has a collaboration with Orbit Biomedical, Ltd. The company was formerly known as BioTime, Inc. and changed its name to Lineage Cell Therapeutics, Inc. in August 2019. Lineage Cell Therapeutics, Inc. was founded in 1990 and is headquartered in Carlsbad, California.
Volume medio
2.16 million shs
TAPPA DEL MERCATO
$416.97 million
Borsa valori
NYSEAMERICAN
Compri queste azioni!
|
NOME
|
TICKER
|
INDUSTRIA
|
SETTORE
|
VOLUME
|
COMPRI ORA QUESTE AZIONI
|
|---|---|---|---|---|---|
|
AMEX:LCTX
|
Prodotti biologici, eccetto diagnostici
|
Medico
|
39,559 shs
|
Below is a quick guide on how to buy AMEX:LCTX stocks safe, fast and around the world in less than five minutes.
Passo 1: Aprire un conto con eToro – eToro is the best broker to buy Lineage Cell Therapeutics shares in the world as you won’t pay any commissions. To do this, visit the eToro website and open an account, it is 100% safe and they offer a huge amount of stocks.
Passo 2: caricare il suo ID - Come da regolamento KYC eToro le chiederà di caricare una copia del suo passaporto o della sua patente di guida.
Passo 3: Deposito di fondi - Depositi del denaro nel suo conto eToro appena creato. Può scegliere tra bonifico bancario, e-wallet o carta di debito/credito o Paypal.
Passo 4: Buy Lineage Cell Therapeutics – Search for “”AMEX:LCTX”” and click on the “”Trade”” button. Enter the total amount of your investment (minimum $50) and confirm the order by clicking the “”Open Trade”” button. And that’s it: you have just bought Lineage Cell Therapeutics stocks with 0% commission!.
1 | | Deposito minimo $50 Promozione esclusiva | Il nostro punteggio 10 ★★★★★ | 0% commissione |
5 Wall Street research analysts have issued “buy,” “hold,” and “sell” ratings for Lineage Cell Therapeutics in the last year. There are currently 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should “buy” Lineage Cell Therapeutics stock.
Wall Street analysts have given Lineage Cell Therapeutics a “Buy” rating, but there may be better short-term opportunities in the market. Some of Reportlab’s past winning trading ideas have resulted in 5-15% weekly gains. Reportlab just released five new trading ideas, but Lineage Cell Therapeutics wasn’t one of them. Reportlab thinks five stocks may be even better buys in the how to buy stocks guide.
1 | | Deposito minimo $50 Promozione esclusiva | Il nostro punteggio 10 ★★★★★ | 0% commissione |
2 |  | Deposito minimo $50 Promozione esclusiva | Il nostro punteggio 10 ★★★★★ | 0% commissione |
3 |  | Deposito minimo $50 Promozione esclusiva | Il nostro punteggio 10 ★★★★★ | 0% commissione |
It can be difficult to navigate through all the outdated and incorrect information related to purchasing AMEX:LCTX stocks. We believe that stocks should be accessible for all, which is why we’ve created this handy guide on where to buy Lineage Cell Therapeutics stocks with a step by step approach.
You’ll need to register with a broker, in these times you can’t go without once and it’s crucial to use a regulated broker that’s allowed to operate there, otherwise, you risk losing funds. eToro is one such broker, and one of the best brokers to buy Lineage Cell Therapeutics stocks with 0% comission, to sign up just click on open account in the following table or compare other options.
Poiché eToro è una piattaforma regolamentata, dovrà completare il processo KYC, questa è una pratica standard e richiede solo un paio di minuti. Dovrà fornire un documento d'identità con foto (passaporto, patente) e una prova di indirizzo (bolletta, estratto conto bancario).
Una volta iscritto e verificato il suo conto, dovrà depositare dei fondi. eToro accetta carte di credito/debito, trasferimenti bancari e anche portafogli elettronici. Quindi qualunque sia la sua preferenza ci sarà qualcosa per lei.
Now that you’ve funded your eToro account, just type “AMEX:LCTX stocks" nella barra di ricerca nella parte superiore dello schermo e prema "trade".
All that’s left is to buy some AMEX:LCTX stock. Simply enter the amount you want to purchase and hit the “buy” button. The amount you bought will be automatically credited to your account where you can monitor its performance.
All in all, AMEX:LCTX is an incredibly interesting company that has the potential to solve some major issues in the business space. After reading this guide you should know how to buy this investment using the best broker or platform. We recommend eToro to anyone looking for a regulated, easy-to-use, fully-featured broker to buy Lineage Cell Therapeutics stocks. As with any broker or online platform, it’s crucial you set up 2FA when using their tools as it ensures your funds are completely safe.
Lineage Cell Therapeutics is scheduled to release its next quarterly earnings announcement on Thursday, March 11th 2021.
View our earnings forecast for Lineage Cell Therapeutics.
Lineage Cell Therapeutics, Inc. (NYSEAMERICAN:LCTX) released its quarterly earnings results on Wednesday, November, 4th. The company reported ($0.05) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.05). The company earned $0.57 million during the quarter, compared to the consensus estimate of $0.65 million. Lineage Cell Therapeutics had a negative net margin of 1,001.59% and a negative trailing twelve-month return on equity of 26.07%.
View Lineage Cell Therapeutics’ earnings history.
5 brokers have issued 1 year price objectives for Lineage Cell Therapeutics’ shares. Their forecasts range from $3.00 to $6.00. On average, they anticipate Lineage Cell Therapeutics’ stock price to reach $4.33 in the next year. This suggests a possible upside of 55.9% from the stock’s current price.
View analysts’ price targets for Lineage Cell Therapeutics or view top-rated stocks among Wall Street analysts.
Lineage Cell Therapeutics’ management team includes the following people:
Mr. Brian M. Culley, CEO, Pres & Director (Age 50, Pay $772.74k)
Ms. Brandi L. Roberts, Chief Financial Officer (Age 47, Pay $550.01k)
Mr. Chase C. Leavitt, Gen. Counsel & Corp. Sec. (Age 40, Pay $321.79k)
Ioana C. Hone, Director of Investor Relations
Mr. James Knight, Sr. VP & Head of Corp. Devel.
Dr. François Binette M.Sc., Ph.D., Sr. VP & Global Head of R&D
Dr. Gary S. Hogge D.V.M., Dvm, Ms, Ph.D., Sr. VP of Clinical & Medical Affairs (Age 53)
Mr. William Annett, Pres & CEO of OncoCyte Corp. (Age 67)
Dr. Rami Skaliter, Chief Exec. Officer of Cell Cure Neurosciences Ltd. (Age 63)
Dr. Harold D. Waitz, VP of Regulatory Affairs & Quality Control (Age 79)
Launched in 2006, eToro is, in our opinion, without a doubt the best broker for buying AMEX:LCTX stocks in the world. The onboarding process is simple, it’s designed to make sure even those new to the stock market are ready to start investing the shortest amount of time possible. As a regulated platform you gain several benefits, most importantly, you know they’re not going to run off with your hard-earned money./
Oltre 95% dei fondi dei clienti sono tenuti offline, in depositi freddi, il che è fondamentale per qualsiasi broker che gestisce i suoi beni. Indipendentemente da quanto sia sicura una piattaforma, raccomandiamo di usare 2FA per aggiungere un ulteriore livello di sicurezza al suo conto.
eToro offre agli utenti una serie di caratteristiche per iniziare ad investire il più rapidamente possibile. Hanno una caratteristica relativamente unica chiamata copy trading, che le permette di guadagnare un reddito passivo facendo da specchio a trader esperti, questo le permette di iniziare a guadagnare rapidamente e le dà una migliore comprensione delle strategie usate dai professionisti. Inoltre, eToro permette agli utenti di investire in portafogli gestiti, un portafoglio gestito è una varietà di asset simili raggruppati insieme, che le permette di diversificare il suo conto, riducendo qualsiasi rischio potenziale. Per chi ha esperienza di trading precedente, può investire in mercati al di fuori delle azioni, dato che eToro permette agli utenti di commerciare ETF, materie prime, cripto e indici. Se già investe al di fuori dello spazio del mercato azionario questo può essere molto utile, perché le permette di gestire tutti i suoi investimenti in un solo posto.
Some companies that are related to Lineage Cell Therapeutics include Inhibrx (INBX), Adverum Biotechnologies (ADVM), Krystal Biotech (KRYS), Cortexyme (CRTX), Coherus BioSciences (CHRS), Vaxcyte (PCVX), Taysha Gene Therapies (TSHA), Mesoblast (MESO), Cellectis (CLLS), Rubius Therapeutics (RUBY), Black Diamond Therapeutics (BDTX), Sutro Biopharma (STRO), Passage Bio (PASG), Agenus (AGEN) and TCR2 Therapeutics (TCRR).
View all of LCTX’s competitors.
Based on aggregate information from Reportlab, some companies that other Lineage Cell Therapeutics investors own include Matinas BioPharma (MTNB), Bionano Genomics (BNGO), Gran Tierra Energy (GTE), ADMA Biologics (ADMA), Novan (NOVN), Pennsylvania Real Estate Investment Trust (PEI), Cannabics Pharmaceuticals (CNBX), Enerplus (ERF), KushCo (KSHB) and Zosano Pharma (ZSAN).
I CFD sono strumenti complessi e comportano un alto rischio di perdere denaro rapidamente a causa della leva. Il 68% dei conti degli investitori al dettaglio perdono denaro quando scambiano CFD con questo fornitore. Deve considerare se capisce come funzionano i CFD e se può permettersi di correre l'alto rischio di perdere i suoi soldi.
Lineage Cell Therapeutics trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol “LCTX.”
Lineage Cell Therapeutics’ stock is owned by a number of institutional and retail investors. Top institutional shareholders include Defender Capital LLC. (3.16%), BlackRock Inc. (1.07%) and Wealth Architects LLC (0.01%). Company insiders that own Lineage Cell Therapeutics stock include Brian M Culley, Broadwood Partners, LP and Chase C Leavitt.
View institutional ownership trends for Lineage Cell Therapeutics.
LCTX stock was sold by a variety of institutional investors in the last quarter, including Defender Capital LLC..
View insider buying and selling activity for Lineage Cell Therapeutics or view top insider-selling stocks.
LCTX stock was bought by a variety of institutional investors in the last quarter, including Wealth Architects LLC, and BlackRock Inc.. Company insiders that have bought Lineage Cell Therapeutics stock in the last two years include Brian M Culley, Broadwood Partners, LP, and Chase C Leavitt.
View insider buying and selling activity for Lineage Cell Therapeutics or or view top insider-buying stocks.
1 | | Deposito minimo $50 Promozione esclusiva | Il nostro punteggio 10 ★★★★★ | 0% commissione |
Shares of LCTX can be purchased through any online brokerage account. Popular online brokerages with access to the stock market include Recensione di Interactive Brokers, Recensione di eToro, Recensione di DEGiro, Recensione di AvaTrade, Recensione di IG Markets, Rassegna dei mercati IC, Recensione di CMC Markets, Recensione di Admiral Markets e molti altri. Legga una delle recensioni per scoprire tutto sul broker e inizi a comprare azioni ora.
One share of LCTX stock can currently be purchased for approximately $2.78.
Lineage Cell Therapeutics has a market capitalization of $416.97 million and generates $3.52 million in revenue each year. The company earns $-11,710,000.00 in net income (profit) each year or $0.14 on an earnings per share basis.
Lineage Cell Therapeutics employs 50 workers across the globe.
The official website for Lineage Cell Therapeutics is www.lineagecell.com.
Lineage Cell Therapeutics is headquartered at 2173 SALK AVENUE SUITE 200, CARLSBAD CA, 92008.
A Reportlab.org vogliamo assicurarci che lei abbia tutte le informazioni più rilevanti su acquisto di azioni. Le portiamo le migliori guide sul mercato azionario con recensioni personali, informazioni di base, recensioni di piattaforme, how to's e altro. Vuole ottenere altre informazioni? Allora dia un'occhiata al Azioni OTC, Azioni del NASDAQ, Azioni del NYSE, Azioni LON, Scorte FRA, Azioni ETR, Scorte dell'EPA, Azioni del TSX o Azioni Amex. Cercando informazioni più dettagliate come 5g stock, azioni biotecnologiche, azioni d'oro e altre informazioni dal nostro reportlab.
How can you buy Lineage Cell Therapeutics stock on the internet?
You can easily buy Lineage Cell Therapeutics stocks with one of the well known regulated brokers on the internet. You can open an account within 5 minutes, make deposits with countless payment providers and trade with professional tools on their platform. At the moment, our visitors rate eToro as the most popular choice.
Un'altra opzione è usare un broker regolamentato come Mercati IC o Brokers interattivi. You can an account with these brokers and start buying or trading AMEX:LCTX stocks in a safe and complete environment to trade in.
Where to buy Lineage Cell Therapeutics stock?
You will first want to find a licensed broker that supports AMEX:LCTX stock. One of our favourite brokers, eToro for example, allows you to make investments into this asset from just $25 and only charges you the spread. Another option is using a regulated broker like DEGIRO or Interactive Brokers. You can open an account with these brokers and start buying or trading AMEX:LCTX stocks in a safe and complete environment.
Is AMEX:LCTX stock a good investment?
As with any other asset, there is an element of risk associated with buying AMEX:LCTX stocks. Therefore, you will want to study the market and make a decision based on your financial standing and the risk you are willing to take.
Is Lineage Cell Therapeutics stock safe to invest in?
All stocks are volatile, or affected by market circumstances. The case with AMEX:LCTX is no different, with its price fluctuating dramatically within short periods. As such, if the market goes against you, then you will end up facing a loss. We advice you to do research first before investing in Lineage Cell Therapeutics stock.
How do you trade Lineage Cell Therapeutics stocks?
You can trade stocks by first opening an account with a regulated platform and making a deposit in US dollars, EUROs or other currency. Next, search for Lineage Cell Therapeutics stock and choose from a buy or sell order – depending on whether you think the stock asset will rise or fall in value. If you speculated on AMEX:LCTX stocks correctly, you will have made a profit. The size of your trading profit will ultimately be determined by your stake and at what percentage your position grew.
How to sell Lineage Cell Therapeutics stock?
To sell your AMEX:LCTX stocks investment, you can sign in to your broker account and cash out directly from within your portfolio. If you have stored the stocks elsewhere, you will first have to transfer them to a third-party provider or broker to cash out.
What is the best Lineage Cell Therapeutics stock trading platform?
eToro, is a top-rated platform for beginners, albeit, it charges significantly lower fees. For example, there are no fees to deposit with a debit/credit card and you only need to cover the spread when trading AMEX:LCTX stock.
Stephen conosce molto bene i prodotti finanziari e in particolare ha una grande passione per i mercati azionari e i suoi partecipanti. Speriamo che le informazioni fornite le siano utili. C'è qualcosa di poco chiaro? Lasci le sue domande o commenti in fondo alla pagina.
| Il nostro punteggio ★★★★★ | |
| Il nostro punteggio ★★★★★ | |
| Il nostro punteggio ★★★★★ |
Notiziario
Notizie recenti
| |
Il nostro punteggio |
0% commissione |
Dati in tempo reale su azioni e criptovalute
Notifiche, Consigli e Notizie
Le migliori guide su azioni e criptovalute
Recensioni su broker e scambi online
Reportlab Finanza è un sito web puramente informativo e non implica in nessun caso consigli di investimento. Tutti gli investimenti comportano rischi e lei può perdere tutti i suoi investimenti. Non investa denaro che non può permettersi di perdere.
Reportlab Finanza
38 Holburn Lane
Heckfield Green
IP21 0UB
Regno Unito
Copyright © 2022 Reportlab.Finance | Tutti i diritti riservati.
